Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating

Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial

Featured Article:

K. Annika Tovote, Joke Fleer, Evelien Snippe, Anita C.T.M. Peeters, Paul M.G. Emmelkamp, Robbert Sanderman, Thera P. Links, and Maya J. Schroevers

Diabetes Care Volume 37: 2427-2434

September, 2014

STUDY OBJECTIVE 

• To assess the efficacy of individual mindfulness-based cognitive therapy (MBCT) and individual cognitive behavior therapy (CBT) compared with a waiting-list control condition for treating depressive symptoms in adults with type 1 or type 2 diabetes

Tovote K. A. al. Diabetes Care 2014;37:2427-2434

STUDY DESIGN AND METHODS

• 94 outpatients with diabetes and comorbid depressive symptoms were randomized to MBCT, CBT, or waiting list

• All participants completed written questionnaires and interviews at pre- and post-measurement

• Primary outcome measure was severity of depressive symptoms

• Anxiety, well-being, diabetes-related distress, and HbA1c levels were assessed as secondary outcomes

Tovote K. A. al. Diabetes Care 2014;37:2427-2434

RESULTS

• Participants receiving MBCT and CBT reported significantly greater reductions in depressive symptoms than patients in the waiting-list control condition

• Both interventions also had significant positive effects on anxiety, well-being, and diabetes-related distress

• No significant effect was found on HbA1c

Tovote K. A. al. Diabetes Care 2014;37:2427-2434

Tovote K. A. al. Diabetes Care 2014;37:2427-2434

CONCLUSIONS

• Both individual MBCT and CBT are effective in improving psychological symptoms in individuals with type 1 and type 2 diabetes

Tovote K. A. al. Diabetes Care 2014;37:2427-2434

Tovote K. A. al. Diabetes Care 2014;37:2427-2434

Tovote K. A. al. Diabetes Care 2014;37:2427-2434